To expand host range, some reovirus variants evolved in Junctional Adhesion Molecule-A (JAM-A)-deficient cell lines, acquiring mutations in the σ1 and μ1 proteins that enabled binding to sialic acid coreceptors, thereby improving infection efficiency in a broader spectrum of cancer cells (87). The gene discussed is F11R; the disease is cancer.